Johnson & Johnson : What You Need to Know About Johnson & Johnson's 2022 Second-Quarter Earnings
July 19, 2022 at 06:54 am EDT
Share
Share
Did you like reading this story? Click the heart to show your love.
expand
This morning, Johnson & Johnson shared its second-quarter performance.
Since its founding in 1886, the company has grown to become one of the world's largest and most broadly based healthcare companies, with approximately 144,000 employees across the globe working every day to help change the trajectory of health for humanity.
"We are proud to have delivered on the robust operational guidance that we set forth at the beginning of the year, as we've continued to advance breakthrough innovation and foster patient access to make a positive impact across many areas of healthcare," says Joe WolkJoe WolkExecutive Vice President and Chief Financial Officer, Johnson & Johnson, Executive Vice President and Chief Financial Officer, Johnson & Johnson. "Johnson & Johnson is strongly positioned to continue making progress on our business priorities, including the creation of the New Consumer Health Company, to deliver both near- and long-term value to all of our Credo stakeholders."
For more details about the company's 2022 second-quarter results, and to read a message from Chief Executive Officer Joaquin DuatoJoaquin DuatoChief Executive Officer, Johnson & Johnson, here's an infographic that highlights key stats.
Share
Did you like reading this story? Click the heart to show your love.
expand
Johnson & Johnson's 2022 2nd-Quarter Earnings
Read the earnings press release, which includes full financial data for the second quarter of 2022.
Learn more
Want to see more company earnings information? Find Johnson & Johnson's past quarterly and full-year results here.
Did you like reading this story? Click the heart to show your love.
Johnson & Johnson
Janssen
Johnson & Johnson Medical Devices Companies
Johnson & Johnson Consumer Health
Johnson & Johnson earnings
Attachments
Original Link
Original Document
Permalink
Disclaimer
Johnson & Johnson published this content on 19 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 July 2022 10:53:08 UTC.
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:
- pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;
- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;
- consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.
At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25).
Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
JOHNSON & JOHNSON 
